Wellness
Persperity Health raises £1 million for sweat-sensing technology
Persperity Health, a new company spun out of The California Institute of Technology, has raised $1 million in pre-seed funding to accelerate the development of its sweat-sensing technology that provides real-time, non-invasive hormonal insights.
The technology enables real-time hormone monitoring through device-based sweat analysis, enabling non-invasive hormone monitoring for women ad providing personalised health insights.
Sweat contains a wealth of information about hormonal health, including critical hormones like estradiol, progesterone, and luteinizing hormone (LH), which are vital to women’s reproductive health and overall wellbeing.
Persperity’s technology leverages a non-invasive process called iontophoresis to induce sweat on demand, allowing women to monitor their hormone levels anytime, anywhere—without strenuous exercise or invasive procedures.
“If you look at what’s commercially available, devices can track heartbeat and steps, but they aren’t capable of studying your health at a molecular level,” said Dr. Wei Gao, co-founder and inventor of the core technology at Persperity Health.
“By analysing sweat, our device provides detailed information about what’s happening inside your body. Once you realise the potential of sweat for health monitoring, it’s hard to go back to conventional methods.”
Persperity Health has also announced its involvement in a $3 million ARPA-H Spark Award aimed at accelerating innovation in women’s health. Spearheaded by Principal Investigator Dr. Wei Gao at Caltech, the project was one of only 23 awardees selected from over 1,700 global applicants to advance a wearable sweat-sensing system for chronic pain assessment, especially benefiting women.
Dr. Pauline M. Maki, co-investigator on the grant, commented: “This innovative technology has the potential to transform women’s health research by enabling, for the first time, the non-invasive collection of biological markers in sweat, including oestrogen—a crucial factor in numerous health conditions that disproportionately affect women, such as migraine.”
With the new capital, Persperity Health has stated it will accelerate product development, pursue strategic partnerships, and navigate the regulatory approval process, with the long-term goal of expanding its platform to analyse additional biomarkers, with potential applications in mental health, stress management, and early detection of other women’s health issues.
Mira has launched an at-home cortisol tracking kit that allows women to monitor stress-related patterns over time using urine samples.
The Cortisol Pattern Kit measures urinary free cortisol directly from a urine sample and displays results through the company’s existing monitor and app.
The system is intended for repeated testing rather than a single measurement, allowing users to compare results with a personal baseline built from their own data.
Mira said consistent daily testing can establish a baseline in about a week. It recommends testing in the morning and evening to see how cortisol patterns change throughout the day.
Cortisol is involved in the body’s stress response but is not a direct or complete measure of stress. The company said the kit is intended for general wellness use and is not designed to diagnose stress, an endocrine condition or any other medical condition.
The Cortisol Pattern Wands use the same lateral-flow testing format as Mira’s existing hormone tests. Users dip a wand into a urine sample, insert it into the Mira Monitor and view the result in the app within minutes.
The company said cortisol data can be viewed alongside cycle, hormone and daily routine information.
Sylvia Kang, founder and chief executive of Mira, said: “The Cortisol Pattern™ Kit gives women a new way to understand their stress patterns over time, in the context of their own biology.”
She added: “We built Mira to give women answers they had spent far too long searching for, beginning with the TTC journey and expanding into hormone and cycle tracking across life stages, including perimenopause. Now, we’re taking Mira beyond reproductive health and into everyday wellness, bringing personalised stress-pattern tracking directly into women’s homes.”
Mira said more than 350,000 women already use its platform to track their cycle and hormones.
Waitlist sign-ups for the Cortisol Pattern Kit and Cortisol Pattern Wands opened on 22 September, with wand refills available to pre-order in 20- and 30-count options.
Manchester City has launched a female athlete health platform covering menstrual, pelvic and breast health, as well as nutrition.
The Her City website is designed for the club’s women’s first-team players, coaches, support staff, academy players and parents.
Manchester City says the platform is the first of its kind in the Women’s Super League and was developed over two years.
The project was led by director of performance services Emma Deakin, physical performance scientist Rosie Anderson and PhD student and first-team nutritionist Sarah Malone.
It grew out of PhD research into menstrual, pelvic and breast health and nutrition, with the team seeking to turn that work into an online educational resource.
The website divides the four areas into separate sections and provides peer-reviewed information that the club says has been critically analysed by experts.
Content will continue to be reviewed and updated as further evidence emerges.
Resources include posters, visual explainers, audio materials and downloadable educational content, with information tailored to different groups including players and parents.
The platform aims to improve knowledge, develop critical analysis skills and strengthen communication within football and at home.
It also includes material to help users assess misinformation they encounter on social media or elsewhere.
A confidential contact form allows users to raise concerns or ask questions directly of experts at Manchester City.
Parents of academy players can also access the platform, with resources intended to help them support their children during a key phase of their development.
Manchester City said its longer-term aim is to make the platform available to all women working across City Football Group.
Small bowel microbiome differences between women and men may help explain why some conditions are more common in women, a study suggests.
The small bowel microbiome is the community of microorganisms living in this part of the digestive tract, where they play vital roles in immune function, metabolism and hormonal regulation.
Researchers found differences between women and men in the composition and organisation of these microbial communities. One bacterial community containing Granulicatella was found only in women.
The study was conducted by investigators at Cedars-Sinai Health Sciences University.
Ruchi Mathur, director of clinical research and clinical operations for the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai and corresponding author of the study, said: “One intriguing finding was a bacterial community containing Granulicatella, which we found only in women.
“Bacteria in this community appear at increased levels in women with polyendocrine metabolic ovarian syndrome, formerly known as polycystic ovary syndrome.”
The researchers also identified differences between women and men in how microbes in the small bowel produce fructans, complex carbohydrates known to trigger digestive symptoms in irritable bowel syndrome (IBS).
IBS is far more common in women than men.
Mathur, who is also a professor of medicine, said: “Our findings show that biological sex is a critical variable in the small bowel microbiome.
“We must consider it as we move toward more personalised approaches to understanding and treating disease.”
Diagnosis2 days agoTrust to decide how far back to review unnecessary breast cancer surgeries
Cancer3 days agoNew test could cut need for invasive womb cancer checks
Cancer5 days agoHigher BMI in early adulthood linked to lower breast cancer risk after menopause
Business & startups4 days agoPersonalising women’s health with AI
Motherhood2 days agoUK commits £254m to boost women’s maternal healthcare choices
Menstrual & gynaecological health4 days agoMira launches at-home cortisol tracking kit
Diagnosis4 days agoTargeted nanotherapy shows endometriosis promise
Motherhood2 days agoParents given new right to two weeks’ leave after pregnancy loss